covaxin

Bharat Biotech has successfully registered 23,000 participants, moving towards achieving the target of involving 26,000 participants for the Phase III clinical trial of Covid-19 anti-vaccine covaxin.  Bharat Biotech is developing this vaccine in association with the Indian Council of Medical Research (ICMR) – Indian Institute of Virology (IIV). Vaccine manufacturer Bharat Biotech said in a … Read more